Skip to main content
. 2020 May 13;19(12):1502–1516. doi: 10.1080/15384101.2020.1757936

Figure 2.

Figure 2.

STAT1 was involved in LINC01123 aberrant expression. (a) GEPIA analyzed the expression of STAT1 in EC using TCGA data. (b) Correlation between LINC01123 and STAT1 in EC tumor specimens was analyzed by GEPIA. (c) Jaspar predicted the possible binding sites between STAT1 and LINC01123 promoter. (d) qPCR examined STAT1 levels in 106 EC specimens. (e) qPCR determined STAT1 levels. (f) qPCR measured LINC01123 levels. (g) ChIP assays. (h) Luciferase reporter assays. * P < 0.05, **P < 0.01.